Deerfield Management Company, L.P. (Series C) Aerie Pharmaceuticals Inc Transaction History

Deerfield Management Company, L.P. (Series C)

$4.84 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $1.02 Million - $2.44 Million	159,985 Added 3.41%	4,855,005 $73.5 Million
Q4 2021 Feb 14, 2022	BUY	$7.02 - $13.33 $12.1 Million - $22.9 Million	1,718,000 Added 57.71%	4,695,020 $33 Million
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $24.4 Million - $35.8 Million	2,151,083 Added 260.44%	2,977,020 $33.9 Million
Q2 2021 Aug 16, 2021	BUY	$15.16 - $18.97 $5.03 Million - $6.29 Million	331,721 Added 67.12%	825,937 $13.2 Million
Q1 2021 May 17, 2021	SELL	$13.12 - $20.9 $8.76 Million - $14 Million	-667,817 Reduced 57.47%	494,216 $8.83 Million

Q4 2020 Feb 16, 2021	BUY	$9.12 - $14.49 $6.09 Million - $9.68 Million	667,817 Added 135.13%	1,162,033 $15.7 Million
Q2 2020 Aug 14, 2020	SELL	$12.0 - $16.13 $24.5 Million - $32.9 Million	-2,037,931 Reduced 80.48%	494,216 $7.3 Million
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $9 Million - $19.4 Million	759,892 Added 42.88%	2,532,147 $34.2 Million
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $49.6 Million - $70.2 Million	-2,796,569 Reduced 61.21%	1,772,255 $42.8 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $28.3 Million - $43 Million	1,535,837 Added 50.64%	4,568,824 $87.8 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $41.3 Million - $68.7 Million	1,424,202 Added 88.53%	3,032,987 $89.6 Million
Q1 2019 May 15, 2019	BUY	$36.32 - $49.25 $3.28 Million - $4.44 Million	90,189 Added 5.94%	1,608,785 $76.4 Million
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $721,116 - $1.31 Million	-21,852 Reduced 1.42%	1,518,596 $54.8 Million
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $59.3 Million - $78.1 Million	1,056,393 Added 218.24%	1,540,448 $94.8 Million
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $7.56 Million - $9.68 Million	-148,631 Reduced 23.49%	484,055 $28.9 Million
Q3 2017 Nov 13, 2017	BUY	$48.6 - $60.1 $30.7 Million - $38 Million	632,686	632,686 $30.7 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account